When Amy was diagnosed with breast cancer, she was scared. Her Oncotype DX Breast DCIS Score result made her feel in control.
New Pan-Cancer Tissue Test
The Oncotype MAP Pan-Cancer Tissue Test delivers rapid, comprehensive tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer.
Our Response to COVID-19
Oncotype DX tests remain readily available and that our laboratory continues to operate. Our patient-critical work teams continue to operate, following all safety procedures and practices.
Ineffective cancer treatments exact human as well financial costs. Oncotype IQ tests have saved more than $3.5 billion in the US.